| 2025-11-03 |
详情>>
股本变动：
变动后总股本24045.55万股
|
| 2025-11-03 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-3.45欧元,归母净利润-8.31亿欧元,同比去年增长10.13%
|
| 2025-11-03 |
财报披露：
美东时间 2025-11-03 盘前发布财报
|
| 2025-08-04 |
详情>>
业绩披露：
2025年中报每股收益-3.33欧元,归母净利润-8.02亿欧元,同比去年增长28.54%
|
| 2025-05-05 |
详情>>
业绩披露：
2025年一季报每股收益-1.73欧元,归母净利润-4.16亿欧元,同比去年增长-31.96%
|
| 2025-03-10 |
详情>>
业绩披露：
2024年年报每股收益-2.77欧元,归母净利润-6.65亿欧元,同比去年增长-171.51%
|
| 2025-03-10 |
详情>>
业绩披露：
2022年年报每股收益38.78欧元,归母净利润94.34亿欧元,同比去年增长-8.34%
|
| 2024-11-04 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-3.83欧元,归母净利润-9.25亿欧元,同比去年增长-295.77%
|
| 2024-08-05 |
详情>>
业绩披露：
2024年中报每股收益-4.67欧元,归母净利润-11.23亿欧元,同比去年增长-460.13%
|
| 2024-05-06 |
详情>>
业绩披露：
2024年一季报每股收益-1.31欧元,归母净利润-3.15亿欧元,同比去年增长-162.74%
|
| 2024-04-08 |
股东大会：
将于2024-05-17召开股东大会
会议内容 ▼▲
- 1.Presentation of the adopted annual financial statements, the approved consolidated financial statements and the combined management report for the Company and the Group, as well as the report of the Supervisory Board, in each case for the 2023 financial year and as of December 31, 2023, respectively.
2.Resolution on the appropriation of balance sheet profit for the 2023 financial year.
3.Resolution on the approval of the actions of the Management Board.
4.Resolution on the approval of the actions of the Supervisory Board.
5.Resolution on the appointment of the auditor and the group auditor for the 2024 financial year as well as the auditor for any audit or review of interim financial information.
6.Resolution on the approval of the Compensation Report.
7.Resolution on the approval of the adjusted Compensation System for members of the Management Board.
8.Resolution on the adjustment of the Compensation System and the compensation of the Supervisory Board members as well as the corresponding amendment to Art. 9 para. 6 of the Articles of Association.
9.Resolution on the cancellation of an existing authorization and the creation of a new authorization to issue bonds with warrants and/or convertible bonds and to exclude subscription rights, together with the cancellation of the existing Conditional Capital WSV 2019 and the creation of a new Conditional Capital WSV 2024 as well as corresponding amendment to the Articles of Association.
10.Resolution on the authorization to acquire treasury shares, also excluding tender rights, and to use them, also excluding subscription rights, as well as the cancellation of the existing authorization.
11.Resolution on the authorization to use derivatives in connection with the acquisition of treasury shares.
12.Amendment of authorizations to issue stock options.
13.Resolution on the partial cancellation and amendment of an authorization to issue stock options, the partial cancellation of the Conditional Capital ESOP 2017/2019 and ESOP 2021, the creation of a new authorization to issue stock options (ESOP 2024) and a new Conditional Capital ESOP 2024 and corresponding amendments to the Articles of Association.
14.Resolution on the approval of the conclusion of a domination and profit and loss transfer agreement between BioNTech SE and BioNTech Collaborations GmbH.
|
| 2024-03-20 |
详情>>
业绩披露：
2023年年报每股收益3.87欧元,归母净利润9.30亿欧元,同比去年增长-90.14%
|
| 2023-11-06 |
详情>>
业绩披露：
2023年三季报(累计)每股收益1.96欧元,归母净利润4.72亿欧元,同比去年增长-93.4%
|
| 2023-04-13 |
股东大会：
将于2023-05-25召开股东大会
会议内容 ▼▲
- 1.Presentation of the Adopted Annual Financial Statements, the Approved Consolidated Financial Statements and the Combined Management Report for the Company and the Group, as well as the report of the Supervisory Board, in each case for the 2022 Financial Year and as of 31 December 2022, respectively.
2.Resolution on the Appropriation of Balance Sheet Profit for the 2021 Financial Year.
3.Resolution on the Appropriation of Balance Sheet Profit for the 2022 Financial Year.
4.Resolution on the Approval of the Actions of the Management Board.
5.Resolution on the Approval of the Actions of the Supervisory Board.
6.Resolution on the Appointment of the Auditor of the Annual Financial Statements and the Auditor of the Consolidated Financial Statements for the 2023 Financial Year as well as the Auditor for any Audit or Review of Interim Financial Information During the Year.
7.Resolution on the Approval of the Remuneration Report.
8.Resolution on Elections to the Supervisory Board.
9.Resolution on the Amendment of Sec. 16 para. 5 of the Articles of Association to Authorize the Management Board to Provide for the Holding of a Virtual Annual General Meeting.
10.Resolution on the Amendment of Sec. 16 para. 4 of the Articles of Association concerning the Participation of Supervisory Board Members in the Annual General Meeting by means of Video and Audio Transmission.
11.Resolution on the Approval of the Conclusion of Four Domination and Profit and Loss Transfer Agreements.
|
| 2023-04-13 |
股东大会：
将于2023-05-25召开股东大会
会议内容 ▼▲
- 1.Presentation of the Adopted Annual Financial Statements, the Approved Consolidated Financial Statements and the Combined Management Report for the Company and the Group, as well as the report of the Supervisory Board, in each case for the 2022 Financial Year and as of 31 December 2022, respectively.
2.Resolution on the Appropriation of Balance Sheet Profit for the 2021 Financial Year.
3.Resolution on the Appropriation of Balance Sheet Profit for the 2022 Financial Year.
4.Resolution on the Approval of the Actions of the Management Board.
5.Resolution on the Approval of the Actions of the Supervisory Board.
6.Resolution on the Appointment of the Auditor of the Annual Financial Statements and the Auditor of the Consolidated Financial Statements for the 2023 Financial Year as well as the Auditor for any Audit or Review of Interim Financial Information During the Year.
7.Resolution on the Approval of the Remuneration Report.
8.Resolution on Elections to the Supervisory Board.
9.Resolution on the Amendment of Sec. 16 para. 5 of the Articles of Association to Authorize the Management Board to Provide for the Holding of a Virtual Annual General Meeting.
10.Resolution on the Amendment of Sec. 16 para. 4 of the Articles of Association concerning the Participation of Supervisory Board Members in the Annual General Meeting by means of Video and Audio Transmission.
11.Resolution on the Approval of the Conclusion of Four Domination and Profit and Loss Transfer Agreements.
|
| 2022-04-21 |
股东大会：
将于2022-06-01召开股东大会
会议内容 ▼▲
- 1.Presentation of the Adopted Annual Financial Statements, the Approved Consolidated Financial Statements, and the Combined Management Report for the Company and the Group as well as the report of the Supervisory Board for the Company, each for the 2021 Financial Year or as of 31 December 2021, respectively.
2.Resolution on the Appropriation of the Balance Sheet Profit
3.Approval of the Actions of the Management Board
4.Approval of the Actions of the Supervisory Board
5.Appointment of the Auditor for the 2022 Financial Year
6.Resolution on the Approval of the Remuneration Report
7.Resolution on the Amendment of Sec. 9 para. 1 of the Articles of Association (Expansion of the Supervisory Board)
8.Resolutions on Elections to the Supervisory Board
9.Resolution on the Remuneration and on the Remuneration System for the Members of the Supervisory Board and an Amendment to Sec. 9 para. 6 of the Articles of Association.
10.Conclusion of Inter-Company Agreements.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2020-07-01 |
复牌提示：
2020-07-01 08:55:09 停牌，复牌日期 2020-07-01 09:50:00
|